powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1649530007
Phillip Joseph
M.D.
Pulmonary Disease
New Haven,
CT
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
87.4
Quality
77.4
Cost
74.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.52%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$408
Payment records
4
By payment type
Food and Beverage
$408
Top paying entities
Food and Beverage
$408
PRESCRIBING · PART D · 2024
Total Rx claims
830
Beneficiaries
—
Total drug cost
$5.3M
Distinct drugs
19
Brand share
46.0%
Top prescribed drugs
Sildenafil Citrate
168 claims
Treprostinil
113 claims
Tadalafil
87 claims
Treprostinil Diolamine
52 claims
Ambrisentan
47 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
467
Unique beneficiaries
—
Total services
580
Distinct HCPCS
12
Medicare payment
$46K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 210 Pulmonary Disease providers in CT — above median (cohort median 666).
